Related references
Note: Only part of the references are listed.Integrated analysis of human genetic association study and mouse transcriptome suggests LBH and SHF genes as novel susceptible genes for amyloid-beta accumulation in Alzheimer's disease
Yumi Yamaguchi-Kabata et al.
HUMAN GENETICS (2018)
Novel recessive mutations in MSTO1 cause cerebellar atrophy with pigmentary retinopathy
Kazuhiro Iwama et al.
JOURNAL OF HUMAN GENETICS (2018)
Pathomechanisms of TDP-43 in neurodegeneration
Ju Gao et al.
JOURNAL OF NEUROCHEMISTRY (2018)
CLCN2 chloride channel mutations in familial hyperaldosteronism type II
Ute I. Scholl et al.
NATURE GENETICS (2018)
TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD
Matthew A. White et al.
NATURE NEUROSCIENCE (2018)
Muscle Fibers Secrete FGFBP1 to Slow Degeneration of Neuromuscular Synapses during Aging and Progression of ALS
Thomas Taetzsch et al.
JOURNAL OF NEUROSCIENCE (2017)
Analysis of the expression patterns of the novel large multigene TRIM gene family (finTRIM) in zebrafish
Kai Luo et al.
FISH & SHELLFISH IMMUNOLOGY (2017)
The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes
Dorota Monies et al.
HUMAN GENETICS (2017)
Recessive mutations in MSTO1 cause mitochondrial dynamics impairment, leading to myopathy and ataxia
Alessia Nasca et al.
HUMAN MUTATION (2017)
Enhanced expression of ADCY1 underlies aberrant neuronal signalling and behaviour in a syndromic autism model
Ferzin Sethna et al.
NATURE COMMUNICATIONS (2017)
Amyotrophic lateral sclerosis
Orla Hardiman et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Augmented quantal release of acetylcholine at the vertebrate neuromuscular junction following tdp-43 depletion
Stefania Dzieciolowska et al.
PLOS ONE (2017)
Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis
Shunmoogum A. Patten et al.
JCI INSIGHT (2017)
MSTO1 is a cytoplasmic pro-mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans
Aniko Gal et al.
EMBO MOLECULAR MEDICINE (2017)
Modelling amyotrophic lateral sclerosis: progress and possibilities
Philip Van Damme et al.
DISEASE MODELS & MECHANISMS (2017)
Mutations in CAPN1 Cause Autosomal-Recessive Hereditary Spastic Paraplegia
Ziv Gan-Or et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
ALS: Recent Developments from Genetics Studies
Martine Therrien et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)
Decoding ALS: from genes to mechanism
J. Paul Taylor et al.
NATURE (2016)
Parkinson-like phenotype in insulin-resistant PED/PEA-15 transgenic mice
Giuseppe Perruolo et al.
SCIENTIFIC REPORTS (2016)
Defining the spectrum of frontotemporal dementias associated with TARDBP mutations
Paola Caroppo et al.
NEUROLOGY-GENETICS (2016)
A Novel Mutation in ELOVL4 Leading to Spinocerebellar Ataxia (SCA) With the Hot Cross Bun Sign but Lacking Erythrokeratodermia A Broadened Spectrum of SCA34
Kokoro Ozaki et al.
JAMA NEUROLOGY (2015)
ELOVLS Mutations Cause Spinocerebellar Ataxia 38
Eleonora Di Gregorio et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
Fishing for causes and cures of motor neuron disorders
Shunmoogum A. Patten et al.
DISEASE MODELS & MECHANISMS (2014)
The phenotypic variability of amyotrophic lateral sclerosis
Bart Swinnen et al.
NATURE REVIEWS NEUROLOGY (2014)
The Role of Muscle microRNAs in Repairing the Neuromuscular Junction
Gregorio Valdez et al.
PLOS ONE (2014)
Expanding the Clinical Phenotype Associated With ELOVL4 Mutation Study of a Large French-Canadian Family With Autosomal Dominant Spinocerebellar Ataxia and Erythrokeratodermia
Maxime Cadieux-Dion et al.
JAMA NEUROLOGY (2014)
Calcium Channel Agonists Protect against Neuromuscular Dysfunction in a Genetic Model of TDP-43 Mutation in ALS
Gary A. B. Armstrong et al.
JOURNAL OF NEUROSCIENCE (2013)
Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational analytical study
Christel Depienne et al.
LANCET NEUROLOGY (2013)
Pharmacological reduction of ER stress protects against TDP-43 neuronal toxicity in vivo
Alexandra Vaccaro et al.
NEUROBIOLOGY OF DISEASE (2013)
Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature
A. Chio et al.
NEUROEPIDEMIOLOGY (2013)
ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43
Eveline S. Arnold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Tadahiro Shimazu et al.
SCIENCE (2013)
EMRE Is an Essential Component of the Mitochondrial Calcium Uniporter Complex
Yasemin Sancak et al.
SCIENCE (2013)
Methylene Blue Protects against TDP-43 and FUS Neuronal Toxicity in C. elegans and D. rerio
Alexandra Vaccaro et al.
PLOS ONE (2012)
Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments
Vivek Swarup et al.
BRAIN (2011)
TDP-43 regulates its mRNA levels through a negative feedback loop
Youhna M. Ayala et al.
EMBO JOURNAL (2011)
Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice
Lionel M. Igaz et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Inactivation of fibroblast growth factor binding protein 3 causes anxiety-related behaviors
Yasunari Yamanaka et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice
Ya-Fei Xu et al.
MOLECULAR NEURODEGENERATION (2011)
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43
Magdalini Polymenidou et al.
NATURE NEUROSCIENCE (2011)
FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis
Edor Kabashi et al.
PLOS GENETICS (2011)
Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo
Edor Kabashi et al.
HUMAN MOLECULAR GENETICS (2010)
Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice
Ya-Fei Xu et al.
JOURNAL OF NEUROSCIENCE (2010)
Progressive motor weakness in transgenic mice expressing human TDP-43
Nancy R. Stallings et al.
NEUROBIOLOGY OF DISEASE (2010)
Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy
Angela S. Laird et al.
PLOS ONE (2010)
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Iga Wegorzewska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structural and functional diversification in the teleost S100 family of calcium-binding proteins
Andreas M. Kraemer et al.
BMC EVOLUTIONARY BIOLOGY (2008)
The SMN binding protein Gemin2 is not involved in motor axon outgrowth
Michelle L. McWhorter et al.
DEVELOPMENTAL NEUROBIOLOGY (2008)
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
Edor Kabashi et al.
NATURE GENETICS (2008)
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis
Jemeen Sreedharan et al.
SCIENCE (2008)
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Tetsuaki Arai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann et al.
SCIENCE (2006)
Cloning of cDNA encoding a regeneration-associated muscle protease whose expression is attenuated in cell lines derived from Duchenne muscular dystrophy patients
Y Nakayama et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)